ReShape Lifesciences
Price & Volume
Stats
See more52W Range | $1.01-$16.58 |
Market Cap | $3.6M |
Shares Short | 22,551 |
Financials
See moreRevenue (12 Mos) | $8M |
Revenue Growth (YoY) | -12.8% |
Gross Profit (12 Mos) | $6.8M |
Diluted EPS | $76.20 |
News
See moreYahoo Finance • 7 days ago
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
Yahoo Finance • 20 days ago
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
Yahoo Finance • 29 days ago
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – RSLS, TURN, RDW, NEUE
Yahoo Finance • last year
ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
About
CEO | Mr. Paul F. Hickey |
CFO | Mr. Thomas Stankovich |
Address | 18 Technology Drive, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 29 |
